GIP
CTSO icon

Granite Investment Partners’s Cytosorbents Corp CTSO Stock Holding History

Granite Investment Partners’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-32,359
Closed -$163K – 302
2019
Q3 		$163K Hold
32,359
– – 0.01% 331
2019
Q2 		$214K Sell
32,359
-78,171
-71% -$537K 0.01% 325
2019
Q1 		$837K Buy
110,530
+51,679
+88% +$402K 0.05% 255
2018
Q4 		$476K Hold
58,851
– – 0.03% 256
2018
Q3 		$760K Hold
58,851
– – 0.04% 203
2018
Q2 		$671K Hold
58,851
– – 0.04% 203
2018
Q1 		$415K Buy
+58,851
New +$445K 0.03% 233

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

Granite Investment Partners's CTSO Position: Q4 2019 in Review

Granite Investment Partners sold out of Cytosorbents Corp (CTSO) in Q4 2019, closing a stake of 32,359 shares — an estimated $163K sold.

Granite Investment Partners first reported a position in CTSO in Q1 2018 and held it in 7 quarters. The position peaked at $837K in Q1 2019. 72 funds tracked by Wall St. Rank hold CTSO as of Q4 2019.

  • Granite Investment Partners reported no remaining Cytosorbents Corp position as of Q4 2019 after selling out during the quarter.
  • Granite Investment Partners sold 32,359 Cytosorbents Corp shares in Q4 2019, an estimated $163K.
  • Granite Investment Partners first reported a position in Cytosorbents Corp in Q1 2018 and held it in 7 quarters.
  • Granite Investment Partners's Cytosorbents Corp position peaked at $837K in Q1 2019.
  • 72 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2019.

Based on Granite Investment Partners's 13F filing for Q4 2019, filed 10 Feb 2020.